Last reviewed · How we verify
micronized flavonoid fraction
At a glance
| Generic name | micronized flavonoid fraction |
|---|---|
| Sponsor | Center of Endourology "Endocenter" |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome (NA)
- Randomized Control Trial of Micronized Purified Flavonoid Fraction for Post Operative Treatment in Anal Fistula Surgery (PHASE4)
- The Effect of Oral Administration of Hesperidin and Diosmin in Reducing Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients (PHASE3)
- Venoactive Drug Treatment of Pelvic Venous Disorders (PHASE3)
- The Efficacy of Aescin in Combination With Micronized Purified Flavonoid Fraction (MPFF) in the Control of Bleeding and Prevent Recurrence of Acute Internal Hemorrhoids, A Randomized Controlled Trial, A Pilot Study (EARLY_PHASE1)
- The Efficacy of Aescin in Combination With MPFF in the Early Control of Bleeding From Acute Internal Hemorrhoids, A Randomized Controlled Trial (NA)
- The MUFFIN-PTS Trial (PHASE3)
- Surgical Approach for Acute External Thrombosed Hemorrhoidal Disease
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- micronized flavonoid fraction CI brief — competitive landscape report
- micronized flavonoid fraction updates RSS · CI watch RSS
- Center of Endourology "Endocenter" portfolio CI